2023 Texas ACS JAM | Breakout I: Breast & Surgical Oncology
Only Fellows, Associate, Retired, and Senior members eligible to score each session.
0 is the lowest; 5 is the highest
Have a conflict with a presentation, please mark N/A
We appreciate you taking the time to score the session.
OK
AN ULTRASOUND-BASED SCORING SYSTEM TO STRATIFY RISK OF AXILLARY METASTASIS IN BREAST CANCER
Spencer Van Decar MD
Brooke Army Medical Center, San Antonio
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
EVALUATION OF INDOCYANINE GREEN INJECTION FOR SENTINEL LYMPH NODE IDENTIFICATION IN BREAST CANCER PATIENTS WITH LYMPHATIC DISRUPTION
Erika Nourishirazi MD, University of Texas Southwestern Medical Center, Dallas
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
DISPARITIES IN RECEIPT OF GUIDELINE CONCORDANT ADJUVANT RADIATION AFTER BREAST CONSERVING SURGERY FOR EARLY STAGE BREAST CANCER
Gloria Chang MD, University of Texas Southwestern Medical Center, Dallas
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
DEMOGRAPHICS, CLINICAL PRESENTATION, AND OUTCOMES OF HIV INFECTED AND UNINFECTED PATIENTS WITH HEPATOCELLULAR CARCINOMA
Lucia Zhang BS, University of Texas Southwestern Medical Center, Dallas
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH PANCOAST TUMORS: A NATIONAL CANCER DATABASE ANALYSIS
Jessica Cox MS, University of Texas Medical Branch - Galveston, Galveston
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
SERUM IL-6 LEVEL PREDICTS SURVIVAL AND TREATMENT RESPONSE IN GASTRIC AND GASTROESOPHAGEAL JUNCTION CANCER
John Karalis MD, University of Texas Southwestern Medical Center, Dallas
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
RESULTS OF A PHASE I TRIAL OF NEOADJUVANT PALLOV-CC VACCINE IN COLORECTAL CANCER
Ankur Tiwari MBBS, University of Texas Medical Center - San Antonio, San Antonio
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
PROGNOSTIC VALUE AND SURVIVAL OF POSITIVE-MARGIN RESECTIONS FOR PANCREATIC ADENOCARCINOMA IN THE ERA OF NEOADJUVANT THERAPY
Amr Al Abbas MD, University of Texas Southwestern Medical Center, Dallas
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
EVALUATION OF SURVEILLANCE INTERVALS IN HIGH-RISK INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS THAT MAXIMIZES RESECTION OF MALIGNANCY
Menghan Zhao MD, University of Texas HSC - Houston, Houstons
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
DELINEATING THE ROLE OF SOCIAL VULNERABILITY IN COLORECTAL CANCER TREATMENT AND SURVIVAL
Gilbert Murimwa, MD, University of Texas Southwestern Medical Center, Dallas
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
PREDICTORS AND BENEFITS OF MULTIAGENT CHEMOTHERAPY FOR PANCREATIC ADENOCARCINOMA: TIMING MATTERS
Todd Smolinksy MD, Brooke Army Medical Center, San Antonio
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
COST ANALYSIS AND FINANCIAL IMPLICATIONS OF CYTOREDUCTIVE SURGERY AND HIPEC: A US SINGLE CENTER EXPERIENCE
Andres Abreu MD, University of Texas Southwestern Medical Center, Dallas
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
Current Progress,
0 of 12 answered